ArticleACS medicinal chemistry letters2025
A Deep-Learning-Aided Drug Screening Based on Visualization of a Hidden Layer as Chemical Space.
Article in ACS medicinal chemistry letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug discovery using deep learning has attracted much attention. However, deep learning models remain unpolished and do not always provide drug leads. Herein, we propose a drug screening method based on the visualization of a hidden layer in the output process of a graph-convolutional-network-based deep learning. Unlike conventional deep learning methods, our approach allows us to prioritize compounds for experimental testing from numerous candidate compounds predicted to be active by the deep learning model. Additionally, it provides information on the relationships between compound structures and their activity. Using this approach, we efficiently identified new leads for histone deacetylase inhibitors. These findings support the usefulness of our deep-learning-aided screening method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.